Search

Author/Creator Larson, Richard A.

1. A Morphologic and Cytochemical Study of Acute Myelomonocytic Leukemia with Abnormal Marrow Eosinophils Associated with Inv(16)(p13q22). Issue 6 (28th January 2016)

Authors:
Bitter, Mitchell A.; Le Beau, Michelle M.; Larson, Richard A.; Rosner, Michael C.; Golomb, Harvey M.; Rowley, Janet D.; Vardiman, James W.
Journal:
American journal of clinical pathology
Issue:
Volume 81:Issue 6(1984)
Page Start:
733
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Allogeneic Hematopoietic Cell Transplantation for Therapy-Related Myeloid Leukemia following Orthotopic Cardiac Transplantation. (30th March 2013)

Authors:
Lin, Richard J.; Larson, Richard A.; van Besien, Koen; Rich, Elizabeth S.
Other Names:
Allsup D. J. Academic Editor.; Bissé E. Academic Editor.; Kawauchi K. Academic Editor.; Khair K. Academic Editor.; Tsirigotis P. Academic Editor.
Journal:
Case reports in hematology
Issue:
Volume 2013(2013)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy. (14th February 2014)

Authors:
Coutre, Steven E.; Othus, Megan; Powell, Bayard; Willman, Cheryl L.; Stock, Wendy; Paietta, Elisabeth; Levitan, Denise; Wetzler, Meir; Attar, Eyal C.; Altman, Jessica K.; Gore, Steven D.; Maher, Tracy; Kopecky, Kenneth J.; Tallman, Martin S.; Larson, Richard A.; Appelbaum, Frederick R.
Journal:
British journal of haematology
Issue:
Volume 165:Number 4(2014:May)
Page Start:
497
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype. Issue 7 (July 2014)

Authors:
Poiré, Xavier; Moser, Barry K.; Gallagher, Robert E.; Laumann, Kristina; Bloomfield, Clara D.; Powell, Bayard L.; Koval, Gregory; Gulati, Kabir; Holowka, Nicholas; Larson, Richard A.; Tallman, Martin S.; Appelbaum, Frederick R.; Sher, Dorie; Willman, Cheryl; Paietta, Elisabeth; Stock, Wendy
Journal:
Leukemia & lymphoma
Issue:
Volume 55:Issue 7(2014:Jul.)
Page Start:
1523
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Blinatumomab treatment of older adults with relapsed/refractory B‐precursor acute lymphoblastic leukemia: Results from 2 phase 2 studies. Issue 14 (3rd May 2016)

Authors:
Kantarjian, Hagop M.; Stein, Anthony S.; Bargou, Ralf C.; Grande Garcia, Carlos; Larson, Richard A.; Stelljes, Matthias; Gökbuget, Nicola; Zugmaier, Gerhard; Benjamin, Jonathan E.; Zhang, Alicia; Jia, Catherine; Topp, Max S.
Journal:
Cancer
Issue:
Volume 122:Issue 14(2016)
Page Start:
2178
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia. Issue 8 (9th June 2022)

Authors:
Gambacorti‐Passerini, Carlo; Nicolini, Franck Emmanuel; Larson, Richard A.; Aroldi, Andrea; Fontana, Diletta; Piazza, Rocco; le Coutre, Philipp; Antolini, Laura; Assouline, Sarit
Journal:
American journal of hematology
Issue:
Volume 97:Issue 8(2022)
Page Start:
E296
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Characterization of cancer comorbidity prior to allogeneic hematopoietic cell transplantation. Issue 3 (23rd February 2019)

Authors:
D'Angelo, Christopher R.; Novitsky, Brianna; Mee Lee, Sang; Godley, Lucy A.; Kline, Justin; Larson, Richard A.; Liu, Hongtao; Odenike, Olatoyosi; Stock, Wendy; Bishop, Michael R.; Artz, Andrew S.
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 3(2019)
Page Start:
629
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665. Issue 10 (2nd October 2016)

Authors:
DeBoer, Rebecca; Koval, Gregory; Mulkey, Flora; Wetzler, Meir; Devine, Steven; Marcucci, Guido; Stone, Richard M.; Larson, Richard A.; Bloomfield, Clara D.; Geyer, Susan; Mullighan, Charles G.; Stock, Wendy
Journal:
Leukemia & lymphoma
Issue:
Volume 57:Issue 10(2016:Oct.)
Page Start:
2298
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Clinical outcomes of IDH2‐mutated advanced‐phase Ph‐negative myeloproliferative neoplasms treated with enasidenib. (1st May 2020)

Authors:
Patel, Anand A.; Cahill, Kirk; Charnot‐Katsikas, Angella; Liu, Hongtao; Gurbuxani, Sandeep; Thirman, Michael; Kosuri, Satyajit; Artz, Andrew S.; Larson, Richard A.; Stock, Wendy; Segal, Jeremy; Odenike, Olatoyosi
Journal:
British journal of haematology
Issue:
Volume 190:Number 1(2020)
Page Start:
e48
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia. Issue 1 (28th June 2012)

Authors:
Stock, Wendy; Johnson, Jeffrey L.; Stone, Richard M.; Kolitz, Jonathan E.; Powell, Bayard L.; Wetzler, Meir; Westervelt, Peter; Marcucci, Guido; DeAngelo, Daniel J.; Vardiman, James W.; McDonnell, Diane; Mrózek, Krzysztof; Bloomfield, Clara D.; Larson, Richard A.
Journal:
Cancer
Issue:
Volume 119:Issue 1(2013)
Page Start:
90
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗